DNA mismatch repair enzyme activity and gene expression in prostate cancer
- PMID: 11444857
- DOI: 10.1006/bbrc.2001.5187
DNA mismatch repair enzyme activity and gene expression in prostate cancer
Abstract
Microsatellite instability (MSI) of short repetitive sequences in human chromosomal DNA can result from defective DNA mismatch repair function in tumor cells. We hypothesize that DNA mismatch repair (MMR) activity is down-regulated during prostatic carcinogenesis. To test this hypothesis, MMR activities and mismatch repair-related genes were analyzed in five different prostate cancer cell lines. Our results demonstrate that MMR activities were decreased as compared to MMR proficient HeLa cells. Interestingly, LNCaP, PC-3 and DU145 had much lower MMR activities as compared to DUPro and TSUPr1. The MMR-related genes (hMLH1, hPMS1, hPMS2, hMSH2, hMSH3, hMSH6) showed mRNA transcripts in all prostate cancer cell lines. However, Western blotting showed decreased or absent hMLH1 protein expression in PC-3, DU145, DUPro and TSUPr1 cells. Similarly, the hMSH2 protein expression was low or absent in DU145 and LNCaP cells. This is the first report that demonstrates decreased MMR activities is associated with low expression of hMLH1, hMSH2 and other MMR-related proteins in prostate cancer.
Copyright 2001 Academic Press.
Similar articles
-
Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.Int J Oncol. 2003 May;22(5):1033-43. Int J Oncol. 2003. PMID: 12684669
-
Defects of DNA mismatch repair in human prostate cancer.Cancer Res. 2001 May 15;61(10):4112-21. Cancer Res. 2001. PMID: 11358834
-
Mismatch repair and microsatellite instability in esophageal cancer cells.Int J Cancer. 2001 Mar 1;91(5):687-91. Int J Cancer. 2001. PMID: 11267981
-
Molecular basis of HNPCC: mutations of MMR genes.Hum Mutat. 1997;10(2):89-99. doi: 10.1002/(SICI)1098-1004(1997)10:2<89::AID-HUMU1>3.0.CO;2-H. Hum Mutat. 1997. PMID: 9259192 Review.
-
[Gastric cancer and microsatellite instability].Nihon Shokakibyo Gakkai Zasshi. 2002 Sep;99(9):1043-9. Nihon Shokakibyo Gakkai Zasshi. 2002. PMID: 12355890 Review. Japanese. No abstract available.
Cited by
-
Effects of a Novel Thiadiazole Derivative with High Anticancer Activity on Cancer Cell Immunogenic Markers: Mismatch Repair System, PD-L1 Expression, and Tumor Mutation Burden.Pharmaceutics. 2021 Jun 15;13(6):885. doi: 10.3390/pharmaceutics13060885. Pharmaceutics. 2021. PMID: 34203761 Free PMC article.
-
Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer.J Urol. 2008 May;179(5):2020-4. doi: 10.1016/j.juro.2008.01.009. Epub 2008 Mar 20. J Urol. 2008. PMID: 18355840 Free PMC article.
-
Mismatch repair enzyme expression in primary and castrate resistant prostate cancer.Asian J Urol. 2016 Oct;3(4):223-228. doi: 10.1016/j.ajur.2016.09.002. Epub 2016 Sep 12. Asian J Urol. 2016. PMID: 29264190 Free PMC article.
-
A novel approach for characterizing microsatellite instability in cancer cells.PLoS One. 2013 May 6;8(5):e63056. doi: 10.1371/journal.pone.0063056. Print 2013. PLoS One. 2013. PMID: 23671654 Free PMC article.
-
A rhodium(III) complex for high-affinity DNA base-pair mismatch recognition.Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3737-42. doi: 10.1073/pnas.0537194100. Epub 2003 Feb 27. Proc Natl Acad Sci U S A. 2003. PMID: 12610209 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials